{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:40:03Z","timestamp":1750542003475,"version":"3.41.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The aim of this study was to assess the impact of <jats:sup>18<\/jats:sup>F-FDG PET\/CT metabolic parameters obtained at initial staging of vulva carcinoma on survival in women with and without HIV infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-FDG PET\/CT images of women with vulva cancer who are planned for definitive therapy were analyzed. SUV<jats:sub>max<\/jats:sub>, SUV<jats:sub>mean<\/jats:sub>, MTV, and total lesion glycolysis (TLG) as well as whole-body MTV and whole-body TLG were computed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-five women were included with a mean age of 43.44 \u00b1 10.32. The majority of the patients were HIV infected with a median CD4 count of 444.00 cells\/mm<jats:sup>3<\/jats:sup>. The HIV-infected women are younger at diagnosis than their HIV-uninfected counterparts. All patients presented with inguinofemoral lymph node involvement, whereas half the patients had pelvic nodal metastasis. All the patients with distant visceral or skeletal metastasis were HIV infected. The lungs were the most common site of distant metastasis. When comparing the SUV<jats:sub>max<\/jats:sub>, SUV<jats:sub>mean<\/jats:sub>, MTV, TLG, wbMTV, and wbTLG between HIV-infected and HIV-uninfected patients, we did not find statistical differences. Twelve patients (48%) were upstaged to metastatic disease. Seven patients had died at the time of analysis. The wbMTV and wbTLG were significantly higher in nonsurvivors than survivors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-FDG PET\/CT improves initial staging of squamous cell carcinoma among women with and without HIV infection. The whole-body tumor burden assessed by <jats:sup>18<\/jats:sup>F-FDG PET metabolic metrics did not differ between HIV-infected and HIV-uninfected women. A higher whole-burden tumor burden is associated with a higher risk of mortality among women with vulva cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003549","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T06:58:02Z","timestamp":1614409082000},"page":"375-381","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["The Association of Tumor Burden by 18F-FDG PET\/CT and Survival in Vulvar Carcinoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Kgomotso M.G.","family":"Mokoala","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, University of Pretoria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismaheel O.","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thabo","family":"Lengana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gbenga O.","family":"Popoola","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Community Health, University of Ilorin, Ilorin, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tebatso M.G.","family":"Boshomane","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Pretoria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neo P.","family":"Mokgoro","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Pretoria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariza","family":"Vorster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike M.","family":"Sathekge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ijgo.12609","article-title":"Cancer of the vulva","volume":"143","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ygyno.2008.01.041","article-title":"New aspects of vulvar cancer: changes in localization and age of onset","volume":"109","year":"2008","journal-title":"Gynecol Oncol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/ijc.30900","article-title":"Vulvar cancer in high-income countries: increasing burden of disease","volume":"141","year":"2017","journal-title":"Int J Cancer"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/gyno.2001.6466","article-title":"Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases","volume":"84","year":"2002","journal-title":"Gynecol Oncol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/IGC.0000000000000547","article-title":"Changing trends in vulvar cancer incidence and mortality rates in Australia since 1982","volume":"25","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"bib6-20250621","first-page":"295","article-title":"Vulvar intraepithelial neoplasia and vulvar cancer","volume":"23","year":"1996","journal-title":"Obstet Gynecol Clin North Am"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2016.07.009","article-title":"Patterns of distant metastases in vulvar cancer","volume":"142","year":"2016","journal-title":"Gynecol Oncol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/CMAR.S143316","article-title":"Vulvar carcinoma: dilemma, debates, and decisions","volume":"10","year":"2018","journal-title":"Cancer Manag Res"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/IGC.0000000000000975","article-title":"European society of gynaecological oncology guidelines for the management of patients with vulvar cancer","volume":"27","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.AOG.0000202404.55215.72","article-title":"Carcinoma of the vulva","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/AOG.0b013e31819b413f","article-title":"Outcome and patterns of recurrence for international federation of gynecology and obstetrics (FIGO) stages I and II squamous cell vulvar cancer","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1996.tb09731.x","article-title":"Controversies in the management of vulvar carcinoma","volume":"103","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/1097-0142(20000701)89:1<116::AID-CNCR16>3.0.CO;2-4","article-title":"Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study","volume":"89","year":"2000","journal-title":"Cancer"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2006.03.010","article-title":"Patterns and frequency of recurrences of squamous cell carcinoma of the vulva","volume":"103","year":"2006","journal-title":"Gynecol Oncol"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"92","DOI":"10.6004\/jnccn.2017.0008","article-title":"Vulvar cancer, version 1.2017, NCCN clinical practice guidelines in oncology","volume":"15","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10147-017-1193-z","article-title":"Japan Society of Gynecologic Oncology Guidelines 2015 for the treatment of vulvar cancer and vaginal cancer","volume":"23","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1055\/s-0042-103728","article-title":"Diagnosis, therapy and follow-up care of vulvar cancer and its precursors. Guideline of the DGGG and DKG (s2k-level, AWMF registry number 015\/059, November 2015","volume":"76","year":"2016","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/gyno.2002.6605","article-title":"Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer","volume":"85","year":"2002","journal-title":"Gynecol Oncol"},{"key":"bib19-20250621","first-page":"230","article-title":"Whole-body [18F]Fluoro-2-deoxyglucose positron emission tomography scan as combined PET-CT staging prior to planned radical vulvectomy and inguinofemoral lymphadenectomy for squamous vulvar cancer: a correlation with groin node metastasis","volume":"35","year":"2014","journal-title":"Eur J Gynaecol Oncol"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"e7943","DOI":"10.1097\/MD.0000000000007943","article-title":"18F-FDG PET\/CT in preoperative staging of vulvar cancer patients: is it really effective?","volume":"96","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/RLU.0000000000003411","article-title":"18F-FDG PET and 18F-FDG PET\/CT in vulvar cancer: a systematic review and meta-analysis","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","article-title":"FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2016.01.011","article-title":"The impact of FDG-PET\/CT in the management of patients with vulvar and vaginal cancer","volume":"140","year":"2016","journal-title":"Gynecol Oncol"},{"key":"bib25-20250621","first-page":"87","article-title":"Utility of the PET\/CT in vulvar cancer management [in Spanish]","volume":"33","year":"2014","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1590\/0100-3984.2018.0072","article-title":"State of the art in vulvar cancer imaging","volume":"52","year":"2019","journal-title":"Radiol Bras"},{"issue":"Suppl","key":"bib27-20250621","first-page":"71","article-title":"A comparison of 18F-FDG PET\/CT findings in HIV positive compared to HIV negative patients with recurrent cervical cancer","volume":"20","year":"2017","journal-title":"Hell J Nucl Med"},{"journal-title":"Q J Nucl Med Mol Imaging","article-title":"18F-FDG-PET\/CT imaging of uterine cervical cancer recurrence in women with and without HIV infection","year":"2019","key":"bib28-20250621"},{"key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3413\/Nukmed-0965-18-03","article-title":"Prognostic value of pre-treatment F-18 FDG PET metabolic metrics in patients with locally advanced carcinoma of the anus with and without HIV infection","volume":"57","year":"2018","journal-title":"Nuklearmedizin"},{"key":"bib30-20250621","doi-asserted-by":"crossref","first-page":"6","DOI":"10.24218\/jcet.2015.04","article-title":"Anal squamous cell carcinoma in African Americans with and without HIV: a comparative study","volume":"1","year":"2015","journal-title":"J Cancer Epidemiol Treat"},{"key":"bib31-20250621","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/RLU.0000000000002291","article-title":"Prognostic value of volumetric parameters of pretreatment 18F-FDG PET\/CT in esophageal cancer: a systematic review and meta-analysis","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib32-20250621","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s13139-012-0161-9","article-title":"Prognostic significance of metabolic tumor volume measured by (18)F-FDG PET\/CT in operable primary breast cancer","volume":"46","year":"2012","journal-title":"Nucl Med Mol Imaging"},{"key":"bib33-20250621","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/MNM.0000000000000903","article-title":"Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography-derived metabolic parameters in surgically resected clinical-n0 nonsmall cell lung cancer","volume":"39","year":"2018","journal-title":"Nucl Med Commun"},{"key":"bib34-20250621","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00259-011-1934-6","article-title":"Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib35-20250621","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/a-1221-7810","article-title":"18F-FDG PET\/CT imaging of vulva cancer recurrence: a comparison of PET-derived metabolic parameters between women with and without HIV infection","volume":"59","year":"2020","journal-title":"Nuklearmedizin"},{"key":"bib36-20250621","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ygyno.2013.01.017","article-title":"The value of 18F-FDG PET\/CT in recurrent gynecologic malignancies prior to pelvic exenteration","volume":"129","year":"2013","journal-title":"Gynecol Oncol"},{"key":"bib37-20250621","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.canrad.2017.10.003","article-title":"(18F)-FDG PET\/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy","volume":"22","year":"2018","journal-title":"Cancer Radiother"},{"key":"bib38-20250621","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13014-019-1236-x","article-title":"Metabolic parameters of sequential 18F-FDG PET\/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation","volume":"14","year":"2019","journal-title":"Radiat Oncol"},{"key":"bib39-20250621","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2014.12.032","article-title":"Quantitative metabolic parameters measured on F-18 FDG PET\/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer","volume":"136","year":"2015","journal-title":"Gynecol Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:03:36Z","timestamp":1750539816000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003549","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}